IDT Biologika

idt-biologika.com

IDT Biologika is an innovative privately-held company with more than 90 years of experience in research, development, manufacture and distribution of biologics for the global protection of human and animal health.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Research

NRX PHARMACEUTICALS ANNOUNCES NEW FINDING FROM ZYESAMI™ (AVIPTADIL) PHASE 2B/3 CLINICAL TRIAL

NRx Pharmaceuticals | August 30, 2021

news image

NRx Pharmaceuticals announced an additional finding in its phase 2b/3 clinical trial investigating ZYESAMI™ (aviptadil) for the treatment of patients with acute Respiratory Failure due to Critical COVID-19. Previously announced results have focused on survival and recovery from respiratory failure at 60 days, and ZYESAMI's apparent role in preventing rise in the inflammatory cytokine IL-6, known as "Cytokine Storm." NRx's new analysis shows that patients tr...

Read More

EMOTET REEMERGES WITH MASSIVE CAMPAIGN TARGETING PHARMA INDUSTRY

HealthITSecurity | January 20, 2020

news image

Proofpoint is urging all organizations to take steps to shore up any vulnerabilities, after detecting a massive Emotet campaign targeting the pharmaceutical industry. The hacking group behind Emotet is known as TA542. Emotet is a modular botnet able to download and install a wide range of malware. It's also known to steal data and send malicious emails from victims. Proofpoint notes that it can easily spread across networks, leveraging infected devices to launch additional attacks. The notor...

Read More

NEW AMR ACTION FUND STEPS IN TO SAVE COLLAPSING ANTIBIOTIC PIPELINE WITH PHARMACEUTICAL INDUSTRY INVESTMENT OF US$1 BILLION

AMR Action Fund | July 09, 2020

news image

Today, more than 20 leading biopharmaceutical companies announced the launch of the AMR Action Fund, a ground-breaking partnership that aims to bring 2-4 new antibiotics to patients by 2030. These treatments are urgently needed to address the rapid rise of antibiotic-resistant infections – also called antimicrobial resistance, or AMR. The companies have raised so far nearly US$1 billion new funding to support clinical research of innovative new antibiotics that are addressing the most resi...

Read More

Business Insights

ASCENTIAL DIGITAL COMMERCE AND GSK CONSUMER HEALTHCARE ANNOUNCE LAUNCH OF ASCENTIAL DIGITAL COMMERCE CONNECT AT CANNES LIONS

Ascential Digital Commerce and GSK Consumer Healthcare | June 15, 2022

news image

Ascential Digital Commerce, whose technology driven products power brands to win in digital commerce, and GSK Consumer Healthcare, a science-led healthcare company, will join forces on June 20th during the Cannes Lions International Festival of Creativity to launch Ascential Digital Commerce Connect, a first-of-its-kind, data-rich, digital commerce platform that provides C-suite executives with visibility of brand sales and performance from multiple data sources. Ascential Digital Commerce Conne...

Read More
news image

Research

NRX PHARMACEUTICALS ANNOUNCES NEW FINDING FROM ZYESAMI™ (AVIPTADIL) PHASE 2B/3 CLINICAL TRIAL

NRx Pharmaceuticals | August 30, 2021

NRx Pharmaceuticals announced an additional finding in its phase 2b/3 clinical trial investigating ZYESAMI™ (aviptadil) for the treatment of patients with acute Respiratory Failure due to Critical COVID-19. Previously announced results have focused on survival and recovery from respiratory failure at 60 days, and ZYESAMI's apparent role in preventing rise in the inflammatory cytokine IL-6, known as "Cytokine Storm." NRx's new analysis shows that patients tr...

Read More
news image

EMOTET REEMERGES WITH MASSIVE CAMPAIGN TARGETING PHARMA INDUSTRY

HealthITSecurity | January 20, 2020

Proofpoint is urging all organizations to take steps to shore up any vulnerabilities, after detecting a massive Emotet campaign targeting the pharmaceutical industry. The hacking group behind Emotet is known as TA542. Emotet is a modular botnet able to download and install a wide range of malware. It's also known to steal data and send malicious emails from victims. Proofpoint notes that it can easily spread across networks, leveraging infected devices to launch additional attacks. The notor...

Read More
news image

NEW AMR ACTION FUND STEPS IN TO SAVE COLLAPSING ANTIBIOTIC PIPELINE WITH PHARMACEUTICAL INDUSTRY INVESTMENT OF US$1 BILLION

AMR Action Fund | July 09, 2020

Today, more than 20 leading biopharmaceutical companies announced the launch of the AMR Action Fund, a ground-breaking partnership that aims to bring 2-4 new antibiotics to patients by 2030. These treatments are urgently needed to address the rapid rise of antibiotic-resistant infections – also called antimicrobial resistance, or AMR. The companies have raised so far nearly US$1 billion new funding to support clinical research of innovative new antibiotics that are addressing the most resi...

Read More
news image

Business Insights

ASCENTIAL DIGITAL COMMERCE AND GSK CONSUMER HEALTHCARE ANNOUNCE LAUNCH OF ASCENTIAL DIGITAL COMMERCE CONNECT AT CANNES LIONS

Ascential Digital Commerce and GSK Consumer Healthcare | June 15, 2022

Ascential Digital Commerce, whose technology driven products power brands to win in digital commerce, and GSK Consumer Healthcare, a science-led healthcare company, will join forces on June 20th during the Cannes Lions International Festival of Creativity to launch Ascential Digital Commerce Connect, a first-of-its-kind, data-rich, digital commerce platform that provides C-suite executives with visibility of brand sales and performance from multiple data sources. Ascential Digital Commerce Conne...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us